|
PERSPECTIVE
Evidence-Based Medicine In The United States—De Rigueur Or Dream Deferred?
Dan Mendelson and
Tanisha V. Carino
Although evidence-based medicine (EBM) is an important concept for promoting value in health care, meaningful application of EBM tools in commercial settings has proceeded slowly. Barriers to the use of EBM include patient preference, physician resistance, the lack of automated decision support systems, managed care failures, lack of research on which to base decisions, and the inherent subjectivity of interpretations of evidence. Political concern has mirrored these barriers; consequently, Medicare still lacks clear authority to apply many evidence-based decision tools. Dialogue and consensus will be critical in bridging public concern and the eagerness of researchers to apply EBM.
       What's this?
This article has been cited by other articles:
|
|
|
|
 
J. Doherty, M. Tanamor, J. Feigert, and J. Goldberg-Dey
Oncologists' Experience in Reporting Cancer Staging and Guideline Adherence: Lessons From the 2006 Medicare Oncology Demonstration
J. Oncol. Pract,
March 1, 2010;
6(2):
56 - 59.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bloomrosen and D. E Detmer
Informatics, evidence-based care, and research; implications for national policy: a report of an American Medical Informatics Association health policy conference
JAMIA,
March 1, 2010;
17(2):
115 - 123.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
